Status:
COMPLETED
Pneumonitis After Radiotherapy for Lung Cancer
Lead Sponsor:
University Hospital Schleswig-Holstein
Collaborating Sponsors:
Zealand University Hospital
Conditions:
Lung Cancer
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Major goals of radiotherapy include local disease control and improvement of the patients' prognoses. One possible side effect of radiotherapy for lung cancer is radiation pneumonitis. Severe (grade ≥...
Detailed Description
Background Most patients with small-cell lung cancer (SCLC) receive radiotherapy in combination with chemotherapy as definitive treatment. Also, a considerable number of patients with advanced non-sma...
Eligibility Criteria
Inclusion
- Histologically proven lung cancer
- Indication for radiotherapy
- Risk factors for developing radiation pneumonitis
- Age ≥18 years
- Written informed consent
- Capacity of the patient to contract
Exclusion
- Pregnancy, Lactation
- Expected non-compliance
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 5 2022
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT04335409
Start Date
September 1 2020
End Date
December 5 2022
Last Update
June 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Radiation Oncology, University of Lübeck and University Medical Center Schleswig-Holstein, Ratzeburger Allee 160, 23562 Lübeck, Germany
Lübeck, Germany, 23562